Precision Medicine Has Dramatically Increased Survival Rates For One Patient In Ten. Scientists Are Looking To Ai To Help With The Rest
The trouble is, too few patients are so fortunate. Despite a great deal of cancer research conducted over the past few decades, only a handful of targeted therapies have reached clinical practice–between 8-and-15 percent of cancer patients in the US are eligible to receive targeted therapy. We’ve made great strides in cancer treatment, but we need to do better. Part of the problem is that cancer is a complex disease involving not only hundreds of genetic mutations, but other biological mechanisms as well....